HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 36, 2012, Pages 14580-14585

  Caccuri, Francesca ^a   Giagulli, Cinzia ^a   Bugatti, Antonella ^a   Benetti, Anna ^a   Alessandri, Giulio ^b   Ribatti, Domenico ^c   Marsico, Stefania ^d   Apostoli, Paola ^a   Slevin, Mark A ^e   Rusnati, Marco ^a   Guzman, Carlos A ^f   Fiorentini, Simona ^a   Caruso, Arnaldo ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF CALABRIA   (Italy)

^e MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^f HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Akt mediated ERK pathway; Extracellular viral proteins; Surface plasmon resonance; Vasculogenic assays; Virokine

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; PROTEIN KINASE B; PROTEIN P17; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; BINDING AFFINITY; CAPILLARY; CELL NUCLEUS; CELL STRUCTURE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL NUCLEUS; ENDOTHELIUM; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ANTIGENS; HIV INFECTIONS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; SURFACE PLASMON RESONANCE; VASCULAR DISEASES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84865980040     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1206605109     Document Type: Article

References (40)

1. Carmeliet P (2003) Angiogenesis in health and disease. Nat Med 9:653-660.
2. Calabrese LH, et al. (1989) Systemic vasculitis in association with human immunodeficiency virus infection. Arthritis Rheum 32:569-576. (Pubitemid 19146697)
3. Monsuez J-J, et al. (2009) HIV-associated vascular diseases: Structural and functional changes, clinical implications. Int J Cardiol 133:293-306.
4. Lo J, et al. (2010) Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 24: 243-253.
5. Longenecker CT, Hoit BD (2012) Imaging atherosclerosis in HIV: Carotid intima-media thickness and beyond. Transl Res 159:127-139.
6. Slevin M, Krupinski J, Badimon L (2009) Controlling the angiogenic switch in developing atherosclerotic plaques: Possible targets for therapeutic intervention. J Angiogenes Res 1:4.
7. Worm SW, et al. (2009) Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: The Data Collection on Adverse Events of Anti-HIV Drugs (D: A:D Study). Circulation 119:805-811.
8. Torriani FJ, et al.; ACTG 5152s Study Team (2008) Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol 52:569-576.
9. Chi D, et al. (2000) The effects of HIV infection on endothelial function. Endothelium 7:223-242. (Pubitemid 32015782)
10. Bussolino F, Mitola S, Serini G, Barillari G, Ensoli B (2001) Interactions between endothelial cells and HIV-1. Int J Biochem Cell Biol 33:371-390. (Pubitemid 32324005)
11. Voelkel NF, Cool CD, Flores S (2008) From viral infection to pulmonary arterial hypertension: A role for viral proteins? AIDS 22(Suppl 3):S49-S53.
12. Fiorentini S, Giagulli C, Caccuri F, Magiera AK, Caruso A (2010) HIV-1 matrix protein p17: A candidate antigen for therapeutic vaccines against AIDS. Pharmacol Ther 128: 433-444.
13. Fiorentini S, et al. (2004) Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH. Biopolymers 76:334-343. (Pubitemid 39468256)
14. Fiorentini S, et al. (2008) HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype. Proc Natl Acad Sci USA 105:3867-3872. (Pubitemid 351723491)
15. Budka H (1990) Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS). Acta Neuropathol 79:611-619.
16. Popovic M, et al. (2005) Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci USA 102:14807-14812. (Pubitemid 41457137)
17. De Francesco MA, et al. (2002) HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor. Proc Natl Acad Sci USA 99:9972-9977. (Pubitemid 34831157)
18. Marini E, et al. (2008) HIV-1 matrix protein p17 binds to monocytes and selectively stimulates MCP-1 secretion: role of transcriptional factor AP-1. Cell Microbiol 10: 655-666. (Pubitemid 351194093)
19. Giagulli C, et al. (2011) Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. PLoS ONE 6:e17831.
20. Giagulli C, et al. (2012) HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation. Blood 119:2274-2283.
21. + CXC chemokine-induced angiogenic activity. J Immunol 165:5269-5277.
22. Lee J, et al. (1992) Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 267:16283-16287.
23. Leong SR, et al. (1997) IL-8 single-chain homodimers and heterodimers: Interactions with chemokine receptors CXCR1, CXCR2, and DARC. Protein Sci 6:609-617. (Pubitemid 27120057)
24. Murdoch C, Monk PN, Finn A (1999) Cxc chemokine receptor expression on human endothelial cells. Cytokine 11:704-712. (Pubitemid 29428004)
25. Brat DJ, Bellail AC, Van Meir EG (2005) The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-oncol 7:122-133. (Pubitemid 40590513)
26. Rusnati M, Presta M (1996) Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization. Int J Clin Lab Res 26:15-23.
27. Fuster MM, Wang L (2010) Endothelial heparan sulfate in angiogenesis. Prog Mol Biol Transl Sci 93:179-212.
28. De Francesco MA, Baronio M, Poiesi C (2011) HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production. J Biol Chem 286:19541-19548.
29. Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14: 6735-6741.
30. Knall C, Worthen GS, Johnson GL (1997) Interleukin 8-stimulated phosphatidylinosi-tol- 3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proc Natl Acad Sci USA 94:3052-3057.
31. Khalil A, et al. (2011) ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks. Cell Cycle 10:481-491.
32. Cheng GZ, et al. (2008) Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr Cancer Drug Targets 8:2-6. (Pubitemid 351237904)
33. + exchange is critical for vascular endothelial growth factor-mediated extracellular signal-regulated kinase (ERK) 1/2 activation and angiogenic functions of human endothelial cells. J Biol Chem 286:37919-37931.
34. Schraufstatter IU, Chung J, Burger M (2001) IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 280:L1094-L1103.
35. Zhang Y, et al. (2012) Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of EGF-EGFR-PI3K-Akt-Erk pathway. J Cell Physiol 227:35-43.
36. Sima AV, Stancu CS, SimionescuM(2009) Vascular endothelium in atherosclerosis. Cell Tissue Res 335:191-203.
37. Cines DB, et al. (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527-3561. (Pubitemid 28225719)
38. Herrmann J, Lerman LO, Mukhopadhyay D, Napoli C, Lerman A (2006) Angiogenesis in atherogenesis. Arterioscler Thromb Vasc Biol 26:1948-1957. (Pubitemid 44253775)
39. Ginestier C, et al. (2010) CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120:485-497.
40. + CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol Ther 112:139-149. (Pubitemid 44314001)